Immutep stock: buy or sell?
April 6th, 2020
Immutep Limited engages in the research, development, and commercialization of medical biotechnology products in Australia.
Should I buy Immutep stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Having a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Immutep stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Immutep stock a buy?
Financial institutions and banks post stock ratings everyday.Unfortunately, we couldn't detect any rating for IMMP stock for the last month.
Immutep stock analysis
After sliding a hair-raising -7.46% on Friday, Immutep closed today at $0.69 and jumped a great 2.99%.
After sliding a hair-raising -7.46% on Friday, Immutep closed today at $0.69 and jumped a great 2.99%. Since price and SMA200d lines crossed down on Mar/25, IMMP fell $-1.16 per share (-62.70%). Since SMA100d and SMA200d crossed up on January, IMMP price slid a -65.33%. IMMP is soaring again after a 30.00% correction from its last top on Mar/26 at $0.90.
After sliding for 4 weeks, this week Immutep soared a shining 2.99%, closing at $0.69. Last week IMMP plummed a hair-raising -8.96% in just one week. Early March IMMP climbed an exceptional 6.25% in just one week. This week broke a red streak of 4 weeks.
Since late March, when IMMP stock price broke down the 40-weeks moving avarage line, it slid $-1.15 per share (-62.50%). Stocks under the 40-weeks moving average line are usually not recommended for average traders. Since SMA20w and SMA40w crossed up by mid January, IMMP price slid a -66.34%.
Immutep stock price history
Immutep IPO was on April 19th, 2012 at $25.00 per share1. Since then, IMMP stock lost a -97.20%, with a yearly average of -13.90%.
1: Adjusted price after possible price splits or reverse-splits.
Immutep stock historical price chart
IMMP stock reached 52-week highs on February at $3.10, and all-time highs 2012-04-20 with a price of 25.5.
Immutep stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we have not detected any price forecast for Immutep stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Immutep ownershipWhen you are planning to invest in shares of a stock, it's always worth to overview its ownership structure.
Immutep shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.00% of all shares.
In case of Immutep stock, 1.71% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for IMMP stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Immutep:
|Market cap||$26.8 M|
|Total shares||38.9 M|
|Float shares||35.8 M|
|- Institutional holdings (%)||1.7%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Monday, April 6th, 2020|
|Day range||$0.67 - $0.70|
|Average true range||$0.23|
|50d mov avg||$2.03|
|100d mov avg||$1.92|
|200d mov avg||$1.77|
Immutep performanceTo better understand Immutep performance you must compare its gains with other related stocks in same sector or industry. For Immutep, the benchmark is made against .